These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ALDOSTERONE- AND CORTISOL SECRETION RATES IN INFANTS AND CHILDREN WITH CONGENITAL ADRENAL HYPERPLASIA SUGGESTING DIFFERENT 21-HYDROXYLATION DEFECTS IN "SALT-LOSERS" AND "NON SALT-LOSERS". DEGENHART HJ; VISSER HK; WILMINK R; CROUGHS W Acta Endocrinol (Copenh); 1965 Apr; 48():587-601. PubMed ID: 14288879 [No Abstract] [Full Text] [Related]
6. Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol. Limal JM; Rappaport R; Bayard F J Clin Endocrinol Metab; 1977 Sep; 45(3):551-9. PubMed ID: 198427 [No Abstract] [Full Text] [Related]
7. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia. Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of plasma renin activity and plasma aldosterone level during dexamethasone suppression test in non-salt-losers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Kinoshita K; Ishida H; Minowada S; Niijima T Endocrinol Jpn; 1980 Dec; 27(6):747-51. PubMed ID: 7021135 [TBL] [Abstract][Full Text] [Related]
9. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia. Beitins IZ; Bayard F; Kowarski A; Migeon CJ J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790 [No Abstract] [Full Text] [Related]
10. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244 [TBL] [Abstract][Full Text] [Related]
11. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency]. Shibata Y Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324 [TBL] [Abstract][Full Text] [Related]
12. 17-Hydroxyprogesterone in normal children and congenital adrenal hyperplasia. Measurement in serum by radioimmunoassay after thin-layer chromatography. Petersen KE; Christensen T Acta Paediatr Scand; 1979 Mar; 68(2):205-11. PubMed ID: 217232 [TBL] [Abstract][Full Text] [Related]
13. 17-Hydroxyprogesterone in the cosyntropin test: results in normal and hirsute women and in mild congenital adrenal hyperplasia. Gourmelen M; Pham-Huu-Trung MT; Bredon MG; Girard F Acta Endocrinol (Copenh); 1979 Mar; 90(3):481-9. PubMed ID: 218414 [TBL] [Abstract][Full Text] [Related]
14. Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia. Strott CA; Yoshimi T; Lipsett MB J Clin Invest; 1969 May; 48(5):930-9. PubMed ID: 4305376 [TBL] [Abstract][Full Text] [Related]
15. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations. Golden MP; Lippe BM; Kaplan SA; Lavin N; Slavin J Pediatrics; 1978 Jun; 61(6):867-71. PubMed ID: 149950 [TBL] [Abstract][Full Text] [Related]
16. Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone. Youssefnejadian E; David R Clin Endocrinol (Oxf); 1975 Jul; 4(4):451-54. PubMed ID: 168994 [TBL] [Abstract][Full Text] [Related]
17. Salt-losers and non salt-losers in congenital adrenal hyperplasia. Bartter FC Arch Dis Child; 1969 Feb; 44(233):138-9. PubMed ID: 4303934 [No Abstract] [Full Text] [Related]
18. [Renin-angiotensin and hypophyseo-adrenal systems in children suffering from congenital adrenocortical hyperplasia resulting from 21-hydroxylase deficiency]. Kasatkina EP; Tiul'pakov AN; Ibragimova GV; Litvinova NN Probl Endokrinol (Mosk); 1991; 37(6):p66. PubMed ID: 1664952 [TBL] [Abstract][Full Text] [Related]
19. Suppression and stimulation of mineralocorticoid hormones (MCH) in the simple virilizing form of congenital adrenal hyperplasia (CAH) evaluated by the quantitation in adrenal venous blood. Wajchenberg BL; Biglieri EG; Okada H; Malerbi DA; Achando SS; Kater CE J Steroid Biochem; 1983 Jul; 19(1B):655-61. PubMed ID: 6350722 [TBL] [Abstract][Full Text] [Related]
20. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia. Horner JM; Hintz RL; Luetscher JA J Clin Endocrinol Metab; 1979 May; 48(5):776-83. PubMed ID: 219009 [No Abstract] [Full Text] [Related] [Next] [New Search]